Ancora Advisors’s BioTelemetry, Inc. BEAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-79,473
| Closed | -$5.73M | – | 1880 |
|
|
2020
Q4 | $5.73M | Sell |
79,473
-37,400
| -32% | -$1.96M | 0.18% | 141 |
|
|
2020
Q3 | $5.33M | Sell |
116,873
-1,560
| -1% | -$65.2K | 0.21% | 114 |
|
|
2020
Q2 | $5.35M | Sell |
118,433
-44,710
| -27% | -$2M | 0.22% | 108 |
|
|
2020
Q1 | $6.28M | Buy |
163,143
+26,820
| +20% | +$1.23M | 0.29% | 89 |
|
|
2019
Q4 | $6.31M | Buy |
136,323
+10,000
| +8% | +$433K | 0.23% | 121 |
|
|
2019
Q3 | $5.14M | Buy |
+126,323
| New | +$5.45M | 0.22% | 130 |
|
|
2018
Q4 | – | Sell |
-213,643
| Closed | -$13.8M | – | 1356 |
|
|
2018
Q3 | $13.8M | Sell |
213,643
-25,202
| -11% | -$1.41M | 0.53% | 59 |
|
|
2018
Q2 | $10.7M | Sell |
238,845
-15,861
| -6% | -$632K | 0.47% | 63 |
|
|
2018
Q1 | $7.91M | Buy |
+254,706
| New | +$8.38M | 0.36% | 92 |
|
|
2017
Q4 | – | Sell |
-112,630
| Closed | -$3.72M | – | 717 |
|
|
2017
Q3 | $3.72M | Sell |
112,630
-49,969
| -31% | -$1.73M | 0.22% | 148 |
|
|
2017
Q2 | $5.44M | Sell |
162,599
-52,670
| -24% | -$1.57M | 0.35% | 80 |
|
|
2017
Q1 | $6.23M | Sell |
215,269
-26,357
| -11% | -$653K | 0.42% | 61 |
|
|
2016
Q4 | $5.4M | Buy |
241,626
+109,835
| +83% | +$2.15M | 0.39% | 57 |
|
|
2016
Q3 | $2.45M | Buy |
131,791
+37,836
| +40% | +$714K | 0.25% | 116 |
|
|
2016
Q2 | $1.53M | Buy |
+93,955
| New | +$1.38M | 0.18% | 157 |
|
Other funds holding BEAT
Ancora Advisors's BEAT Position: Q1 2021 in Review
Ancora Advisors sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 79,473 shares — an estimated $5.73M sold.
Ancora Advisors first reported a position in BEAT in Q2 2016 and held it in 15 quarters. The position peaked at $13.8M in Q3 2018. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.
- Ancora Advisors reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
- Ancora Advisors sold 79,473 BioTelemetry, Inc. shares in Q1 2021, an estimated $5.73M.
- Ancora Advisors first reported a position in BioTelemetry, Inc. in Q2 2016 and held it in 15 quarters.
- Ancora Advisors's BioTelemetry, Inc. position peaked at $13.8M in Q3 2018.
- 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.
Based on Ancora Advisors's 13F filing for Q1 2021, filed 14 May 2021.